TG Therapeutics Inc
NASDAQ:TGTX
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.49
34.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
TG Therapeutics Inc
Wall Street
Price Targets
TGTX Price Targets Summary
TG Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TGTX
is 38.89 USD
with a low forecast of 9.09 USD and a high forecast of 57.75 USD.
TGTX Last Price Targets
TG Therapeutics Inc
The latest public price target was made on Nov 5, 2024 by
Edward White
from
H.C. Wainwright
,
who expects
TGTX
stock to
rise by 62%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Edward White
H.C. Wainwright
|
55
USD
Upside 62% |
2 weeks ago
Nov 5, 2024
|
TG Therapeutics (TGTX) PT Raised to $55 at H.C. Wainwright
StreetInsider
|
Corinne Jenkins
Goldman Sachs
|
20
USD
Downside 41% |
3 months ago
Aug 6, 2024
|
TG Therapeutics price target raised to $20 from $18 at Goldman Sachs
TheFly
|
|
Edward White
H.C. Wainwright
|
49
USD
Upside 45% |
6 months ago
May 3, 2024
|
TG Therapeutics (TGTX) PT Raised to $49 at H.C. Wainwright
StreetInsider
|
|
Unknown Analyst
Cantor Fitzgerald
|
24
USD
Downside 29% |
1 year ago
Feb 7, 2023
|
Cantor Fitzgerald Maintains Overweight on TG Therapeutics, Raises Price Target to $24
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TGTX's stock price target?
Price Target
38.89
USD
According to Wall Street analysts, the average 1-year price target for
TGTX
is 38.89 USD
with a low forecast of 9.09 USD and a high forecast of 57.75 USD.
What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
48%
For the last 8 years the
compound annual growth rate for
TG Therapeutics Inc's revenue is
151%.
The projected
CAGR
for the next 3 years is
48%.
What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
120%
The
compound annual growth rate
of TG Therapeutics Inc's operating income for the next 3 years is
120%.
What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
182%
The
compound annual growth rate
of TG Therapeutics Inc's net income for the next 3 years is
182%.
You don't have any saved screeners yet
